
|Articles|February 23, 2004
P&T Portfolio: Abarelix
Abarelix injectable suspension (Plenaxis) is a treatment option for patients with advanced prostate cancer who have no alternative therapy.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
PCVs Significantly Reduce Pneumococcal Meningitis in Children
2
PCV20 Shows Significant Cost-Savings, Health Benefits Compared With Previous Vaccines
3
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
4
Q&A: Expert States Loudest Medical Content on Social Media Is Typically Negative
5





































































































































